The estimated Net Worth of Ivan Tornos is at least $7.6 Million dollars as of 6 March 2024. Mr. Tornos owns over 10,270 units of Zimmer Biomet Inc stock worth over $3,406,334 and over the last 6 years he sold ZBH stock worth over $0. In addition, he makes $4,196,910 as Group President - Global Businesses and Americas at Zimmer Biomet Inc.
Sign up
Mr. Tornos ZBH stock SEC Form 4 insiders trading
Ivan has made over 10 trades of the Zimmer Biomet Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 10,270 units of ZBH stock worth $1,079,891 on 6 March 2024.
The largest trade he's ever made was exercising 10,270 units of Zimmer Biomet Inc stock on 6 March 2024 worth over $1,079,891. On average, Ivan trades about 2,257 units every 84 days since 2018. As of 6 March 2024 he still owns at least 32,395 units of Zimmer Biomet Inc stock.
You can see the complete history of Mr. Tornos stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ivan Tornos biography
Ivan Tornos serves as Group President - Global Businesses and Americas of the Company. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Divisions of Becton, Dickinson and Company (“BD”) (and previously, C. R. Bard, Inc. (“Bard”)) from June 2017 until October 2018. From June 2017 until BD’s acquisition of Bard in December 2017, Mr. Tornos also continued to serve as President, Europe, Middle East and Africa (“EMEA”) of Bard, a position to which he was appointed in September 2013. Mr. Tornos joined Bard in August 2011 and, prior to his appointment as President, EMEA, served as Vice President and General Manager with leadership responsibility for Bard’s business in Southern Europe, Central Europe and the Emerging Markets Region of the Middle East and Africa. Before joining Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging Segments of Covidien International from April 2009 to August 2011. Before that, he served as International Vice President, Business Development and Strategy with Baxter International Inc. from July 2008 to April 2009 and, prior to that, Mr. Tornos spent 11 years with Johnson & Johnson in positions of increasing responsibility.
What is the salary of Ivan Tornos?
As the Group President - Global Businesses and Americas of Zimmer Biomet Inc, the total compensation of Ivan Tornos at Zimmer Biomet Inc is $4,196,910. There are 2 executives at Zimmer Biomet Inc getting paid more, with Bryan Hanson having the highest compensation of $11,176,700.
How old is Ivan Tornos?
Ivan Tornos is 44, he's been the Group President - Global Businesses and Americas of Zimmer Biomet Inc since 2019. There are 21 older and 1 younger executives at Zimmer Biomet Inc. The oldest executive at Zimmer Biomet Holdings Inc is Larry Glasscock, 72, who is the Independent Non-Executive Chairman of the Board.
What's Ivan Tornos's mailing address?
Ivan's mailing address filed with the SEC is 345, East Main Street, Warsaw, Kosciusko County, Indiana, 46580, United States.
Insiders trading at Zimmer Biomet Inc
Over the last 9 years, insiders at Zimmer Biomet Inc have traded over $2,148,754,462 worth of Zimmer Biomet Inc stock and bought 59,988 units worth $7,136,091 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Michael W Michelson und Group Inc Blackstone Group .... On average, Zimmer Biomet Inc executives and independent directors trade stock every 19 days with the average trade being worth of $14,226,269. The most recent stock trade was executed by Zuilen Wilfred Van on 1 July 2024, trading 2,633 units of ZBH stock currently worth $276,860.
What does Zimmer Biomet Inc do?
zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.
What does Zimmer Biomet Inc's logo look like?
Complete history of Mr. Tornos stock trades at Zimmer Biomet Inc
Zimmer Biomet Inc executives and stock owners
Zimmer Biomet Inc executives and other stock owners filed with the SEC include:
-
Bryan Hanson,
President, Chief Executive Officer, Director -
Suketu Upadhyay,
Chief Financial Officer, Executive Vice President -
Ivan Tornos,
Group President - Global Businesses and Americas -
Didier Deltort,
President - Europe, Middle East and Africa -
Bryan C. Hanson,
Chairman, Pres & CEO -
Chad Phipps,
Senior Vice President, General Counsel, Secretary -
Sang Yi,
President, Asia Pacific -
Ivan Tornos,
Group Pres of Global Bus.es, The Americas & EMEA Region and COO -
Suketu P. Upadhyay,
Exec. VP & CFO -
Sang Yi,
Group Pres of Asia Pacific -
Larry Glasscock,
Independent Non-Executive Chairman of the Board -
Robert Hagemann,
Independent Director -
Arthur Higgins,
Independent Director -
Betsy Bernard,
Independent Director -
Christopher Begley,
Independent Director -
Gail Boudreaux,
Independent Director -
Michael Farrell,
Independent Director -
Michael Michelson,
Independent Director -
Maria Hilado,
Independent Director -
Syed Jafry,
Independent Director -
Carrie Nichol,
Chief Accounting Officer, Vice President, Controller -
Keri Mattox,
Senior Vice President - Investor Relations, Chief Communications Officer -
Angela Main,
Sr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia Pacific -
Chad F. Phipps,
Sr. VP, Gen. Counsel & Sec. -
Zeeshan Tariq,
Sr. VP & Chief Information Officer -
Dr. Nitin Goyal M.D.,
Chief Science, Technology & Innovation Officer -
Derek M. Davis,
Interim Controller, Chief Accounting Officer, & Principal Accounting Officer -
Louis Shapiro,
Director -
David C Dvorak,
President and CEO -
Paul Bisaro,
Director -
David A. Jr. Nolan,
Group President -
Adam Rudolph Johnson,
Group President -
Cecil B Pickett,
Director -
Katarzyna Mazur Hofsaess,
Pres., Eur., M. East & Afr. -
Robert D. Delp,
President, Americas -
Tony W. Collins,
VP, Controller and CAO -
Jeffrey K. Rhodes,
Director -
Daniel E. Williamson,
Group President -
Zuilen Wilfred Van,
Group Pres, EMEA -
Rachel Ellingson,
SVP & Chief Strategy Officer -
Aure Bruneau,
Group President -
Daniel P Florin,
Exec. VP, CFO -
Sachs Group Incgoldman Sach...,
-
Stuart G. Kleopfer,
President, Americas -
Equity Partners 2004 Direct...,
-
Group Holdings (Sbs) Adviso...,
-
Group Inc Blackstone Group ...,
-
Group L.P.Blackstone Manage...,
-
Capital Partners V L P Blac...,
-
Acquisition Holding, Llc Lvb,
-
Sreelakshmi Kolli,
Director -
Lori Winkler,
SVP and CHRO -
Devdatt Kurdikar,
Director -
Derek M Davis,
Interim Controller & CAO -
Paul A Stellato,
VP, Controller & CAO -
Mark Bezjak,
President, Americas